Other

Merck beats 1Q profit views with tight cost controls

Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, administration and research easily offset lower medicine sales outside the U.S.

Health

New York's rich live 11 years longer than its poor

New York is a city of extreme inequality, where people in the poorest neighborhood of Brooklyn die 11 years earlier than those living around Wall Street, according to data released Wednesday.

Other

Amgen tops Street 4Q forecasts

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

Other

Valeant: We'll bump Allergan offer to $200 a share

The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.

Other

Merck Q4 net drops 14 pct. on generic competition

Merck & Co. reported a 14 percent decline in fourth-quarter profit as generic competition continued to cut into sales of one-time blockbuster medicines, and unfavorable currency exchange rates reduced overseas revenue.

page 1 from 2